Cellebrite DI Ltd.

Informe acción NasdaqGS:CLBT

Capitalización de mercado: US$2.2b

Salud financiera de hoja de balance de Cellebrite DI

Salud financiera controles de criterios 6/6

Cellebrite DI tiene un patrimonio de accionistas total de $34.2M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $532.9M y $498.7M respectivamente. El BAIT de Cellebrite DI es de $33.4M, por lo que su ratio de cobertura de intereses es de -3.8. Tiene efectivo e inversiones a corto plazo que ascienden a $302.9M.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses-3.8x
EfectivoUS$302.92m
PatrimonioUS$34.21m
Total pasivoUS$498.67m
Activos totalesUS$532.89m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Nov 04
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

May 26
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Mar 16
Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Feb 16
Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Feb 09
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Oct 18
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Cellebrite: A Niche Company With A Large TAM

Sep 30

Cellebrite DI Lowers Sights For 2022

Aug 30

Cellebrite Non-GAAP EPS of $0.00 misses by $0.03, revenue of $62.6M misses by $6.5M

Aug 11

Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Jul 08
Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($422.1M) de CLBT superan a sus pasivos a corto plazo ($253.8M).

Pasivo a largo plazo: Los activos a corto plazo de CLBT ($422.1M) superan a sus pasivos a largo plazo ($244.8M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: CLBT está libre de deudas.

Reducción de la deuda: CLBT no ha tenido ninguna deuda en los últimos 5 años.

Cobertura de la deuda: CLBT no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: CLBT no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.


Hoja de balance


Descubre empresas con salud financiera